RecruitingPhase 1NCT06522581

Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Armed Forces Hospital, Pakistan
Principal Investigator
arshad Khushdil, FCPS
PEMH
Intervention
Citicoline Sodium(drug)
Enrollment
200 target
Eligibility
All sexes
Timeline
20242025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06522581 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials